COVERAGE LIVE /SESSION 04 · APR 25 2026 /RESEARCH INDEX · 184 ENTRIES
FRESH 7D 12 /OPEN POSITIONS 14
Eschatos Research
EST. MMXXIV · ISSUE 184
Search ticker, exec, filing…⌘K
Eschatos/Research Index

Every thesis on the desk, fully traceable.

184 writeups across 9 sectors, 5 analysts. Each entry links back to its dossier, screen, and evidence rows. Filter by stance, conviction, sector, or analyst.
Filters
All Long · 28 Short · 9 Watch · 12 Flag · 6
Sector ▾ Analyst ▾ Conviction ▾ Date ▾
Showing 12 of 184 · sort: filed desc
T·184
Coalstone is being repriced as a specialty input, not a building material.
Three quarters of dossier work, transcript reads, and ground-truth checks across eleven plants. Specialty mix is the new operating sentence.
CLST.N
Long · Core
22 Apr · 06:14
T·183
Veridian's CFO transition is the tell, not the headline number.
Working capital choreography ahead of the search firm engagement; defensive timing, not strategic.
VRDN.OPEER:NXTR
Short · Catalyst
21 Apr · 06:08
T·182
Bethel Energy: the depreciation reset everyone is waiting for is structurally late.
Three field accountants and a regulator filing tell a different timeline than sell-side notes.
BTHE.N
Long · Conviction
19 Apr · 14:42
T·181
Halycon Bio's pipeline narrative survives — its capital plan does not.
The science is real. The next financing window isn't. Long thesis paired with a dilution-aware structure note.
HALY.N
Watch · Structure
17 Apr · 11:20
T·180
Sovereign Re's reserve releases are no longer voluntary. They are a tell.
Two consecutive quarters of "favorable development" against a hardening book.
SVRN.N
Short · Governance
15 Apr · 07:55
T·179
Atlas Logistics is being misread as a cyclical. It's an infrastructure compounder.
Throughput per terminal, contract step-ups, and a quietly disciplined buyback. Initiating long with 24-month horizon.
ATLS.N
Long · Initiation
12 Apr · 09:11
T·178
Kryos Materials: a clean compliance file, an unclean ownership chart.
Two beneficial-ownership disclosures don't reconcile. Not a thesis yet — a governance escalation.
KRYO.O
Flag · Open
10 Apr · 17:30
T·177
Mera Therapeutics: indication breadth is a liability, not a moat.
Trial design economics on three programs imply structural underinvestment per indication. Re-rating thesis with attached scoring memo.
MERA.O
Watch · Re-rate
08 Apr · 10:18
T·176
Quorum Aerospace's backlog quality has improved faster than its multiple.
Reading the backlog by program rather than by dollar value tells a cleaner story than the consolidated number.
QORM.O
Long · Adds
06 Apr · 08:32
T·175
Paragon Holdings: the capital allocation framework has quietly reset.
Buyback velocity and segment capex pattern tell a story management has not yet narrated.
PARA.O
Long · Initiation
03 Apr · 16:45
T·174
Catalyst Networks: the interconnect business is mispriced relative to private comps.
Pulling four private market data points and three regulator filings yields a different rev quality picture than the consolidated.
CLST.NEQX
Long · Pair
01 Apr · 09:20
T·173
Holstead Capital: a private-credit book that's earning its multiple — for now.
Origination quality and concentration analysis. We rate the book a B+, the structure a C.
HCAP.N
Watch · Structure
28 Mar · 13:02
Showing 12 of 184. Load more →